Increased selectivity of drugs by linking to carriers
- 1 February 1978
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer (1965)
- Vol. 14 (2), 105-111
- https://doi.org/10.1016/0014-2964(78)90167-6
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Binding of chlorambucil with antitumor globulins and its effect on drug and antibody activitiesEuropean Journal of Cancer (1965), 1976
- Suppression of tumour growth in mice by a drug–antibody conjugate using a novel approach to linkageNature, 1975
- The cure and concomitant immunization of mice bearing Ehrlich ascites tumors by treatment with an antibody-alkylating agent complexEuropean Journal of Cancer (1965), 1973
- Synthesis and biological evaluation of poly-.gamma.-glutamyl derivatives of methotrexateBiochemistry, 1973
- Immunochemotherapy of Cancer with Chlorambucil-carrying AntibodyBMJ, 1972
- Antibody as carrier of chlorambucilCancer, 1972
- Transport d'agents cytostatiques par les protéines plasmatiques: III. Activité antitumorale in vitro de conjugués cytostatique-azoprotéinesEuropean Journal of Cancer (1965), 1969
- Some Serum Protein Nitrogen Mustard Complexes with High Chemotherapeutic SelectivityNature, 1967
- Immunoradioactive agent against cancer.BMJ, 1967
- THE ANTICOAGULANT AND ANTILYMPHOMA PROPERTIES OF ARSENIC AZOPROTEINSThe Journal of Experimental Medicine, 1964